Allergan
Allergan transfers drug patent to Mohawk tribe to sidestep lawsuits
09 Sep 2017
The surprise move by Allergan to transfer the patents on a best-selling eye drug to the Saint Regis Mohawk Tribe could open up a new way for drug makers to head off challenges to patents
Allergan to buy Tobira Therapeutics for $1.7 bn
20 Sep 2016
Allergan to sell US distribution unit Anda to Teva for $500 mn
04 Aug 2016
The sale comes just a day after Teva completed its $40.5-billion acquisition of Allergan’s generic unit, following US regulatory approval a week ago
Pfizer calls halt to $160bn merger with Allergan: report
06 Apr 2016
The decision comes after the US Treasury unveiled new rules that proposed to limit companies’ ability to participate in inversion transactions if they have been engaged in acquisitions within the past 36 months
New Treasury rules threaten Allergan-Pfizer merger
05 Apr 2016
The US Treasury Department has framed new rules to throttle ‘inversions’, in a move seen to be directly prompted by the proposed Allergan-Pfizer merger, which would create the world’s biggest drug firm
European regulator approves Teva’s $40.5-bn Allergan drug unit deal with conditions
11 Mar 2016
The European Commission yesterday approved Teva Pharmaceutical Industries' $40.5-billion acquisition of the generics drug unit of Allergan on condition that it divests some Allergan products in the UK and Ireland
Allergen deal to help Pfizer save $35 bn in annual taxes: report
26 Feb 2016
The Pfizer-Allergen deal is the largest inversion ever, which would potentially lower the merged entity's annual tax bill by $35 billion in the United States
Pfizer to take over Allergan in historic $150-bn deal
23 Nov 2015
The deal, the largest ever in the healthcare sector, will make Pfizer the world’s biggest drug maker, but the tax-cutting ‘inversion’ move is sure to draw political ire
Pfizer said to be in $150-bn merger talks with Allergan
19 Nov 2015
Merger talks are being held between US pharmaceutical giant Pfizer and Irish drug maker Allergan Plc, to create a global pharmaceutical behemoth worth over $300 billion
Pfizer, Allergan mull largest pharma merger
29 Oct 2015
US drug giant Pfizer Inc and Irish pharmaceutical company Allergan Plc are weighing a merger plan, which would create the world’s largest drug company with a market cap of more than $300 billion
Teva in talks to buy Allergan's generic-drug unit for $45 bn: report
27 Jul 2015
A deal with Allergan would indicate that Teva could be considering abandoning its plan to buy Mylan NV after the Netherlands-based company rejected its $40-billion takeover offer
Botox-maker Allergan Plc to buy Kythera Biopharmaceuticals for $2.1 bn
18 Jun 2015
Botox-maker Allergan Plc yesterday struck a deal to buy Kythera Biopharmaceuticals Inc in a $2.1-billion cash-and-stock deal, in a bid to expand its portfolio of cosmetic treatments
Actavis in talks to buy US Botox maker Allergan for around $60 billion: report
13 Nov 2014
Last week Allergan had said it was in talks with a suitor, without identifying ithe bidder, which was widely speculated as being Actavis
Botox maker Allergan in talks with new suitor
07 Nov 2014
Allergan did not name the proposed new suitor, which some media reports speculated might be Actavis Inc
Valeant Pharmaceuticals plans to raise bid for Allergan
08 Oct 2014
Valeant is taking its takeover offer close to a December shareholder meeting where some of Allergan’s directors face removal
Valeant raises Allergan bid to $49.44 bn: analysts say new offer still too low
29 May 2014
A successful deal with Allergan would more than double the size of Valeant and make it one of the largest specialty pharmaceutical companies in the world
Botox maker Allergan rejects Valeant's $45.7-b hostile bid
12 May 2014
Allergan Inc today rejected the hostile takeover offer from Canada’s Valeant Pharmaceuticals International Inc, saying that the $45.7-billion bid substantially undervalued the company
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
